Author

M. G. Ferrari

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Organism:mouse· 1

Frequent Co-Authors

A. Budreika· 1 shared A. M. Chinnaiyan· 1 shared A. Towne· 1 shared B. L. McCollum· 1 shared D. J. Vander Griend· 1 shared J. E. Choi· 1 shared J. G. Thoene· 1 shared J. T. Phoenix· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Budreika

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Clinically relevant humanized mouse models of metastatic prostate cancer to evaluate cancer therapies

R. J. Kostlan, J. T. Phoenix, A. Budreika, M. G. Ferrari, N. Khurana, J. E. Choi, K. Juckette, B. L. McCollum, R. Moskal, Y. Qiao, D. J. Vander Griend, A. M. Chinnaiyan, S. Kregel

This paper develops humanized mouse models of metastatic prostate cancer to evaluate therapies, showing improved immune interactions and response to hormonal and immunotherapies.

bioRxiv · Oct 13, 2023 · PreprintCancer Biology

In Vitro Activity of Cysteamine Against SARS-CoV-2 Variants

J. G. Thoene, R. F. Gavin, A. Towne, L. Wattay, M. G. Ferrari, R. Pal

This study shows cysteamine HCl inhibits multiple SARS-CoV-2 variants in vitro, suggesting potential as a topical nasal treatment to mitigate infection and transmission.

bioRxiv · Oct 2, 2021Microbiology